Cowen Downgrades Pacific Biosciences of California (PACB) to Market Perform
Tweet Send to a Friend
Cowen analyst Doug Schenkel downgraded Pacific Biosciences of California (NASDAQ: PACB) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
